The Infectious Disease (ID) team at Children's Hospital Colorado provides a breadth of expertise ranging from laboratory-based research to the treatment and prevention of infectious diseases, including neonatal infections, serious infections in children
such as pneumonia, meningitis, bone and joint infections, Kawasaki Disease, infections in immunocompromised hosts, and pediatric and adolescent HIV infections. The Infectious Disease program advocates an emphasis on vaccine-preventable diseases through
The Section of Infectious Diseases is committed to educating and training medical students, physician assistants, residents, and fellows. Our faculty and fellows have won numerous teaching awards for their outstanding educational contributions.
Our Section has maintained an active and highly respected fellowship training program for
the past 30 years. Our three-year ACGME fellowship training program provides comprehensive ID clinical experience in addition to broad research opportunities. Physicians who are board eligible in pediatrics will receive at least 12 months of in-depth
training in the clinical and microbiological aspects of infectious diseases. This will include inpatient consulting, infectious diseases clinic, HIV clinic and infection control. At least 21 months will be devoted to research. Upon completion of the
program fellows will be eligible for subspecialty boards.
Training for residents in
pediatric infectious diseases is provided through clinical consultations to the ward team and outpatient clinics. A month-long elective provides a more intensive experience as an infectious diseases consultant and a brief period in the clinical
The Section of Infectious Diseases has an active basic and translational research program with more than $5 million of federal funding yearly.
The Section has over 30 full-time faculty engaged
in a broad range of research, including respiratory viral pathogens, enteric viral diseases, hospital epidemiology, international health, HIV, TB, Kawasaki disease, Staph toxin disease, and vaccine-preventable diseases. We participate in multiple
national clinical trials of antiviral agents, antiretroviral medications, and vaccines.